Viral Vectors

Risk-Based Optimization of Viral Vector Processes Adds Real Value

Elie Hanania, Ph.D.; Tatiana Mello, M.S.

Avid Bioservices

Antibiotic Resistance

Antibiotic Resistance: Advances in Understanding and Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

Column: New Drug Watch

Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Cell and Gene Therapy

State of the Cell and Gene Therapy Market

James Grote

Nice Insight

mRNA

Limitless Potential of mRNA Creates Tremendous Excitement Despite Uncertainties

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Precision Medicine

Examining the Potential of Precision/Personalized Medicine

David Alvaro, Ph.D.

Pharma's Almanac

Column: Supply Chain

Reimagining the Pharmaceutical Supply Chain

Danielle Alvarez

Pharma's Almanac

Big Data

Leveraging Big Data, Artificial Intelligence, and Machine Learning for Drug Discovery, Development, Manufacturing, and More

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac

Future of the Industry

What key indicators do you look at to predict the future of this industry?

Pharma's Almanac

Sustainability

What is your plan to build a more sustainable business practice in the coming years?

Pharma's Almanac

Transient Expression

Overcoming Limitations with Transient Protein Expression to Accelerate Development

Cenk Sumen, Ph.D.

MaxCyte

Clinical Workflow Integration

How All Clinical Trial Stakeholders Can Collaborate as One Study Team

OneStudyTeam

European DCTs

Exploring Challenges and Considerations for Operationalizing DCTs in the European Union

Kamilla Posselt

PPD, part of Thermo Fisher Scientific

Real-Time Monitoring

Raman Spectroscopy as a PAT Tool Advancing Biopharma Manufacturing

Stacy Shollenberger

MilliporeSigma

Digital Health Solutions

Beyond Drug Sales: Adding Value with Digital Health

Gérard Klop; Marcos Gallego Llorente, Ph.D.

Neurodegenerative Disease Clinical Trials

Preparing for Growth in Neurodegenerative Treatment Opportunities: How Clinical Teams can Best Position Study Design and Strategy to Reach Study Participants

John Hamlet; Christine Martino, MPM; Sabine Krofczik-Wilhelm, Ph.D.; Alberto Lledó, M.D., Ph.D.

PPD, part of Thermo Fisher Scientific

Clinical Trials Adherence

Evolving Solutions to Optimize Clinical Trial Decentralization

Tim Rich; John Musaus

PPD, part of Thermo Fisher Scientific

Speed to Clinic

Leveraging Experience to Reduce Timelines for IND-Enabling Activities

Muctarr Sesay, Ph.D.; Andrew Majdoch, M.Sc.

GBI

Biodefense

Supporting Biodefense Countermeasures with Strong Capabilities and Expertise

Brian O’Mara

Scorpius BioManufacturing

CDMO

Asymchem: Leading with Technology

Asymchem